In a larger cohort of patients with advanced cancer at diagnosis before antineoplastic treatment, where patients with ovarian cancer showed the most severe anemia, low hemoglobin levels were associated with high hepcidin and ferritin levels, which were positively correlated with IL-6 [30]. This evidence concerns the gene HAMP and ovarian cancer.